Is this goodbye for Beechams?

The merger between pharmaceutical giants SmithKline Beecham and Glaxo Wellcome poses yet another pretty naming problem. Surely the new company’s own choice – Glaxo SmithKline – is a stopgap.

It presumably must be the case that the loss of both Beecham and Wellcome will not be the final nail in their coffins, and that their brand equity will be reflected in a carefully constructed strategy which optimises their undoubted values – and I don’t mean just the remedies labelled as Beechams.

Also, if a new name is ever introduced, I hope it isn’t another Aventis, or Avensis (or was it Invensys?)

Chris Ludlow

Henrion, Ludlow & Schmidt

London SW1

Recommended

Delaney loses £8.5m Bestfoods

Marketing Week

Bestfoods has switched its Ambrosia and Hellmann’s advertising accounts – with a combined worth of more than &£8.5m – from Delaney Lund Knox Warren to HHCL & Partners and BMP DDB. The move is believed to be part of a rationalisation aimed at reducing the number of agencies on the company’s roster from three to […]

Co-op’s Smile lures Egg Head

Marketing Week

Internet bank Smile has poached Bob Head, commercial director of Prudential’s Egg, to head the operation. Head became the first director of Smile this week. He reports to Co-operative Bank chief executive Mervyn Pedelty. Smile was launched last October, under the management of the Co-operative Bank. Sources say Head has been brought in to build […]

Comments

    Leave a comment